Most of the patients received treatment for type 2 diabetes
Oral semaglutide offers a convenient, effective way to support your metabolic health without the need for needles
Given that our findings suggest that generic pricing may be cost-effective, payers could explore adjusting reimbursement criteria, notes lead investigator Abhinav Sharma, MD, PhD, DREAM-CV Lab, Research Institute, and Centre for Outcome Research & Evaluation, McGill University Health Centre
The molecule in the pen is identical to that in the individual vial
It is no longer: Does this drug work? It is now: Does this drug meaningfully change the patients metabolic trajectory in a GLP-1++ world? If the answer is no, the program is not dead but it is secondary
Visible glow in a month